ÂÜÀòÂÒÂ×

Jenny Robertson joined LEXEO Therapeutics as General Counsel in Q1 2022. Prior to LEXEO, Ms. Robertson served as Chief Counsel to Pfizer’s Oncology Business Unit and has held other senior legal roles including as Chief Counsel for Pfizer’s Rare Disease Business Unit, leading its global legal team for five years. Across positions at Pfizer, Ms. Robertson counseled clients on a range of business and legal matters, including commercialization, disclosure, business development, alliance management, clinical development, intellectual property issues, and litigation. Before joining Pfizer in 2010, Ms. Robertson spent 10 years in private practice with a large international law firm in New York and Washington D.C., engaged in complex commercial litigation with a healthcare law focus. Ms. Robertson holds a Bachelor of Arts Degree in Political Science from Southern Illinois University and a J.D. from the Georgetown University Law Center, where she co-founded and served as Editor-in-Chief of The Georgetown Journal of Gender and the Law.